Roivant Sciences Ltd. (ROIV)
USD 9.51
(-5.04%)
USD 9.51
(-5.04%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -6.03 Billion USD | -404.93% |
| 2023 | -1.19 Billion USD | 32.71% |
| 2022 | -1.77 Billion USD | 1.85% |
| 2021 | -1.81 Billion USD | 9.7% |
| 2020 | -2 Billion USD | -183.79% |
| 2019 | -706.37 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -941.45 Million USD | 12.2% |
| 2024 Q2 | -910.25 Million USD | 63.82% |
| 2024 FY | -6.03 Billion USD | -404.93% |
| 2024 Q3 | -6.16 Billion USD | -577.2% |
| 2024 Q4 | -6.03 Billion USD | 2.08% |
| 2023 Q1 | -1.45 Billion USD | 18.21% |
| 2023 Q2 | -1.12 Billion USD | 22.8% |
| 2023 Q4 | -1.19 Billion USD | -14.09% |
| 2023 Q3 | -1.04 Billion USD | 6.59% |
| 2023 FY | -1.19 Billion USD | 32.71% |
| 2022 Q2 | -2.22 Billion USD | -28.14% |
| 2022 FY | -1.77 Billion USD | 1.85% |
| 2022 Q4 | -1.77 Billion USD | 8.28% |
| 2022 Q1 | -1.73 Billion USD | 4.25% |
| 2022 Q3 | -1.93 Billion USD | 12.78% |
| 2021 Q3 | -2.06 Billion USD | 0.0% |
| 2021 Q1 | 2.18 Billion USD | 200.0% |
| 2021 Q4 | -1.81 Billion USD | 12.43% |
| 2021 FY | -1.81 Billion USD | 9.7% |
| 2020 Q4 | -2.18 Billion USD | 0.0% |
| 2020 FY | -2 Billion USD | -183.79% |
| 2019 FY | -706.37 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -10690.055% |
| Alkermes plc | -166.73 Million USD | -3520.003% |
| Agenus Inc. | 274.13 Million USD | 2301.811% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 422.789% |
| Aptorum Group Limited | 1.35 Million USD | 444886.47% |
| Ardelyx, Inc. | 34.51 Million USD | 17589.444% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 141127.033% |
| Bicycle Therapeutics plc | -481.46 Million USD | -1153.66% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 16790.974% |
| ChromaDex Corporation | -24.04 Million USD | -24999.622% |
| Chimerix, Inc. | -25.51 Million USD | -23554.65% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 86723.008% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -25392.913% |
| CRISPR Therapeutics AG | -150.84 Million USD | -3901.43% |
| Precision BioSciences, Inc. | -85.41 Million USD | -6967.038% |
| Dyadic International, Inc. | -6.37 Million USD | -94535.674% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -37783.368% |
| Fortress Biotech, Inc. | 7.66 Million USD | 78846.993% |
| Lantern Pharma Inc. | -21.7 Million USD | -27711.269% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -5360.576% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -70552.378% |
| Incyte Corporation | -3.17 Billion USD | -90.104% |
| IO Biotech, Inc. | -140.69 Million USD | -4189.979% |
| Jaguar Health, Inc. | 29.39 Million USD | 20636.753% |
| Novavax, Inc. | -298.29 Million USD | -1923.493% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 113196.44% |
| Opthea Limited | 28.15 Million USD | 21536.451% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -35851.855% |
| ContextLogic Inc. | -232 Million USD | -2501.706% |
| MiMedx Group, Inc. | -33.9 Million USD | -17704.658% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 59305.071% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -260404.388% |
| NextCure, Inc. | -6.47 Million USD | -93090.628% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -11852.153% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -94522.308% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 49724.472% |
| Vaxcyte, Inc. | -368.22 Million USD | -1539.195% |
| PDS Biotechnology Corporation | -32.7 Million USD | -18353.562% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 35034.35% |
| Pharming Group N.V. | 109.8 Million USD | 5597.028% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -34597.384% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -3344.591% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -32491.814% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -32491.814% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -84913.479% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -102902.679% |
| Acelyrin, Inc. | -216.9 Million USD | -2682.791% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -107487.696% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -350013.515% |
| Summit Therapeutics Inc. | 34.67 Million USD | 17507.732% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -88624.93% |
| Senti Biosciences, Inc. | 1.74 Million USD | 346994.08% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -3169.625% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -7693.259% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -99470.389% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 6050032.344% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 961239.65% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -5056.91% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -3487.856% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 5544.175% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -79362.309% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -4574.905% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 87646.177% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -2390.461% |
| Immix Biopharma, Inc. | -17.5 Million USD | -34371.896% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -1805.873% |
| MEI Pharma, Inc. | -3.7 Million USD | -162813.819% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 48345.2% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 3831.843% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 21817.544% |
| Fortress Biotech, Inc. | 7.66 Million USD | 78846.993% |
| Precigen, Inc. | -481 Thousand USD | -1254776.715% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 42965.968% |
| AlloVir, Inc. | -62.69 Million USD | -9527.954% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -10753.305% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 9888.144% |
| ImmuCell Corporation | 10.99 Million USD | 55019.457% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -3815.74% |
| Onconetix, Inc. | 5.33 Million USD | 113314.449% |
| PureTech Health plc | -167.19 Million USD | -3510.087% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -19716.011% |
| Elevation Oncology, Inc. | -19.11 Million USD | -31472.115% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -122856.957% |
| Seer, Inc. | -4.24 Million USD | -142257.476% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -25011.108% |
| Innoviva, Inc. | 255.56 Million USD | 2461.827% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -10704.735% |
| ESSA Pharma Inc. | -33.62 Million USD | -17852.625% |
| GlycoMimetics, Inc. | -40.98 Million USD | -14627.44% |
| GT Biopharma, Inc. | -1.02 Million USD | -591080.901% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -8804.824% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 9953.498% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -4401.791% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -43462.045% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -20805.919% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -8012161.396% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -19457.893% |
| Aptose Biosciences Inc. | -8.19 Million USD | -73555.428% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -192802.598% |
| Soligenix, Inc. | -4.95 Million USD | -121799.197% |
| Century Therapeutics, Inc. | 847 Thousand USD | 712727.745% |
| Kura Oncology, Inc. | -20.11 Million USD | -29902.769% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -14648.466% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -71773.744% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 331437.408% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -188700.657% |
| Autolus Therapeutics plc | -186.59 Million USD | -3134.721% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -12142.327% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -2088.574% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 17713.975% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 3772.221% |
| GRI Bio, Inc. | -1.79 Million USD | -336352.453% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -67092.765% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -18049.433% |
| IGM Biosciences, Inc. | -72.6 Million USD | -8213.303% |
| INmune Bio, Inc. | -25.41 Million USD | -23653.323% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 4098.62% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -11814.874% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -37045.786% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -209123.98% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 15977.83% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -14555.717% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 19030.397% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 1697.021% |
| Verastem, Inc. | -37.27 Million USD | -16091.74% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -66426.584% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -11538.496% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -39780.786% |
| Histogen Inc. | -7.48 Million USD | -80519.167% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -27835.425% |
| Surrozen, Inc. | -32.66 Million USD | -18378.928% |
| Organovo Holdings, Inc. | -1.5 Million USD | -400428.003% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -143494.01% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 31934.867% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 230832.301% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 145334.769% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -71918.243% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -13794.289% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -41307.8% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -1805.356% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -835835.656% |
| Apollomics, Inc. | -27.39 Million USD | -21933.061% |
| Amarin Corporation plc | -191.04 Million USD | -3059.525% |
| Mesoblast Limited | 55.96 Million USD | 10885.621% |
| Turnstone Biologics Corp. | -14.58 Million USD | -41287.527% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -23765.084% |
| Synaptogenix, Inc. | -28.66 Million USD | -20959.461% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -644767.201% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 12486.024% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -700054.74% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -82970.335% |
| Exelixis, Inc. | -73.05 Million USD | -8162.775% |
| Better Therapeutics, Inc. | -860 Thousand USD | -701755.465% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -25036.205% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -2400.697% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 820129.318% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -81048.796% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 481436.284% |
| Gritstone bio, Inc. | 39.49 Million USD | 15384.773% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -7077.034% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -229217.476% |
| Avid Bioservices, Inc. | 169.72 Million USD | 3656.253% |
| Insmed Incorporated | 721.62 Million USD | 936.445% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -65927.994% |
| MediWound Ltd. | -5.32 Million USD | -113315.201% |
| OmniAb, Inc. | 9.2 Million USD | 65686.841% |
| Alector, Inc. | -35.63 Million USD | -16837.332% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 7120.922% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -122382.894% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 45692.243% |
| Zai Lab Limited | -775 Million USD | -678.833% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 1872.388% |
| Aura Biosciences, Inc. | -21.52 Million USD | -27941.612% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -7218.086% |
| Immunic, Inc. | -45.34 Million USD | -13212.653% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -3023.959% |
| Veracyte, Inc. | -203.82 Million USD | -2861.357% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 1045.64% |
| FibroGen, Inc. | 56.76 Million USD | 10732.862% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 67881.662% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -213404.844% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -291443.113% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 231.493% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -180563.185% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -3536.907% |
| TG Therapeutics, Inc. | 17.86 Million USD | 33892.168% |
| Galecto, Inc. | -21.21 Million USD | -28350.024% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -25277.158% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 484.603% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -24564.747% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -52354.654% |
| XBiotech Inc. | -200.02 Million USD | -2917.631% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -7077.034% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 133402.937% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -17016.97% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -7716.775% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 106161.448% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -3441.916% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -6434.26% |
| Vaxxinity, Inc. | 10.13 Million USD | 59673.204% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 919.807% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -55956.916% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -9051.49% |
| NexImmune, Inc. | -3.13 Million USD | -192517.889% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -174719.828% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -39842.937% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -22172.904% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -67145.113% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -4845139.414% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -14777.149% |
| Ainos, Inc. | 4.07 Million USD | 148115.291% |
| Pluri Inc. | 22.82 Million USD | 26539.866% |
| Prothena Corporation plc | -608.34 Million USD | -892.19% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -4982.654% |
| Celularity Inc. | 65.19 Million USD | 9359.023% |
| Rallybio Corporation | -24.1 Million USD | -24943.386% |
| Cue Biopharma, Inc. | -33.81 Million USD | -17747.828% |
| MeiraGTx Holdings plc | -40.3 Million USD | -14876.818% |
| Omeros Corporation | 331.17 Million USD | 1922.583% |
| Humacyte, Inc. | -22.48 Million USD | -26743.178% |
| Immunocore Holdings plc | -358.59 Million USD | -1583.229% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -24461.371% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -19433.209% |
| Blueprint Medicines Corporation | 702.83 Million USD | 958.8% |
| CalciMedica, Inc. | -5.53 Million USD | -109049.313% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -3106.863% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -58994.938% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -14975.947% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -18051.616% |
| Pulmatrix, Inc. | -10.41 Million USD | -57843.333% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -100886.398% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -15724.962% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -5318.177% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -9969.324% |
| Cytokinetics, Incorporated | 642.37 Million USD | 1039.636% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -103557.17% |
| Nutriband Inc. | -251.65 Thousand USD | -2398385.637% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -17590.897% |
| Vor Biopharma Inc. | 4.3 Million USD | 140471.093% |
| Evogene Ltd. | -19.63 Million USD | -30642.37% |
| ProKidney Corp. | -56.23 Million USD | -10633.262% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -12301.292% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -65244.103% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 542.55% |
| CorMedix Inc. | -43.05 Million USD | -13919.99% |
| BioLineRx Ltd. | 7.33 Million USD | 82378.585% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -21876.905% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 13179.847% |
| Atai Life Sciences N.V. | -28.55 Million USD | -21035.783% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 270706.524% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -26354.931% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 34134.153% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -7940.01% |
| MediciNova, Inc. | -50.78 Million USD | -11785.662% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -7559.358% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -26832338.32% |
| GeoVax Labs, Inc. | -6.45 Million USD | -93443.181% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -2920.682% |
| Biomea Fusion, Inc. | -166.57 Million USD | -3523.676% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -3272.514% |
| Mereo BioPharma Group plc | -51.46 Million USD | -11627.364% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -6264.089% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -1954.731% |
| Absci Corporation | -72.59 Million USD | -8214.219% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 132293.539% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -2474.661% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -6306.85% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -6207.429% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -15347.898% |
| Allakos Inc. | -24.97 Million USD | -24067.996% |
| Imunon, Inc. | -4.21 Million USD | -143140.84% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -40843.949% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -4357.871% |
| BioAtla, Inc. | -109.01 Million USD | -5437.016% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 820129.318% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -642706.922% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 50542.562% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -28367.467% |
| XOMA Corporation | -29 Million USD | -20713.645% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -36349.016% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -66847.172% |
| aTyr Pharma, Inc. | -7.44 Million USD | -80930.434% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -4742.868% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -2799.616% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -7280.815% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -6406.858% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -702422.044% |
| Akari Therapeutics, Plc | -3.84 Million USD | -156881.977% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 372026.44% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 537.11% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -507919.459% |
| UroGen Pharma Ltd. | 4.39 Million USD | 137562.013% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 5418.914% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 8387800.453% |
| Orgenesis Inc. | 21.78 Million USD | 27808.212% |
| Entera Bio Ltd. | -10.62 Million USD | -56687.628% |
| GH Research PLC | -78.07 Million USD | -7630.775% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -26981.645% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -22541.348% |
| Xencor, Inc. | 29.64 Million USD | 20461.48% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -306322.999% |
| Replimune Group, Inc. | 1.41 Million USD | 427575.708% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -2464481.394% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -4674.64% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -507919.459% |
| Portage Biotech Inc. | -4.98 Million USD | -121079.623% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -26832338.32% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -9028.515% |
| OncoCyte Corporation | -6.56 Million USD | -91869.48% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 672695.227% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -132394.074% |
| Purple Biotech Ltd. | -14.13 Million USD | -42593.146% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -25308.137% |
| scPharmaceuticals Inc. | -6.54 Million USD | -92122.414% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -36060.42% |
| HilleVax, Inc. | -165.48 Million USD | -3547.435% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -237723.365% |
| Tharimmune, Inc. | -10.93 Million USD | -55096.733% |
| Genprex, Inc. | -6.73 Million USD | -89485.773% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -1536.617% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -6723.374% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -430732.049% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -181873.327% |
| OKYO Pharma Limited | -826.84 Thousand USD | -729895.961% |
| Savara Inc. | 153 Thousand USD | 3945169.935% |
| Curis, Inc. | -23.88 Million USD | -25168.795% |
| Daré Bioscience, Inc. | -5.15 Million USD | -116923.287% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -777717.482% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -97128.689% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 509463.46% |
| BeiGene, Ltd. | -2.25 Billion USD | -167.897% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 49019.699% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -892.423% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -3152.377% |
| Erasca, Inc. | -37.21 Million USD | -16118.715% |
| bluebird bio, Inc. | 108.57 Million USD | 5659.456% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -468569.136% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 1693.66% |
| DBV Technologies S.A. | -126.98 Million USD | -4653.246% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -468569.136% |
| Moderna, Inc. | -2.9 Billion USD | -107.635% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -58207.158% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -55438.802% |
| Molecular Templates, Inc. | 707 Thousand USD | 853842.15% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -19140.563% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 1841.436% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -7255.362% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -6480.134% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -18603.387% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -17458.637% |
| MacroGenics, Inc. | -66.98 Million USD | -8910.908% |
| RenovoRx, Inc. | -1.17 Million USD | -514474.339% |
| Adicet Bio, Inc. | -138.78 Million USD | -4249.08% |
| Prime Medicine, Inc. | -27.94 Million USD | -21502.509% |
| Aditxt, Inc. | 18.12 Million USD | 33409.394% |
| Adagene Inc. | -87.62 Million USD | -6788.208% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -144806.046% |
| Quantum-Si incorporated | -118.55 Million USD | -4991.186% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 16864.219% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -80657.361% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -12342.963% |
| SciSparc Ltd. | -2.06 Million USD | -292198.16% |
| Vericel Corporation | 1.27 Million USD | 472766.954% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -50234.452% |
| Minerva Neurosciences, Inc. | 41 Million USD | 14820.321% |
| Generation Bio Co. | 31.44 Million USD | 19293.453% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -3341.959% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -19419.312% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 5276.946% |
| Invivyd, Inc. | -198.47 Million USD | -2941.152% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -6586.559% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -251640.69% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -8426.567% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -88338.93% |
| 2seventy bio, Inc. | 181.71 Million USD | 3421.661% |
| ADMA Biologics, Inc. | 90.06 Million USD | 6801.704% |
| Clene Inc. | 3.34 Million USD | 180817.275% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -66355.514% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -27959.862% |
| GeoVax Labs, Inc. | -6.45 Million USD | -93443.181% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -1654.006% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -23115.502% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 3497.362% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -147421.891% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 120770.872% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -115775.542% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -4532.212% |
| Evaxion Biotech A/S | 5.28 Million USD | 114269.38% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -5262.054% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -4498.019% |
| Trevena, Inc. | 2.25 Million USD | 267414.305% |
| Surrozen, Inc. | -32.66 Million USD | -18378.928% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -11618.03% |
| Cingulate Inc. | 3.08 Million USD | 195902.066% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -205414.368% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 84084.375% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -64864.046% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -7509.34% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -4491.757% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -5619.009% |
| Clearmind Medicine Inc. | -3.94 Million USD | -152994.414% |
| Kronos Bio, Inc. | -36.05 Million USD | -16641.436% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 64250.887% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 414052.763% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -11024.958% |
| Statera Biopharma, Inc. | 14.41 Million USD | 41968.667% |
| ImmunityBio, Inc. | 618.22 Million USD | 1076.338% |
| Korro Bio, Inc. | -132.94 Million USD | -4440.259% |
| Kineta, Inc. | -4.54 Million USD | -132821.317% |
| BioVie Inc. | -17.73 Million USD | -33939.237% |
| Codexis, Inc. | -43.27 Million USD | -13849.197% |
| Celularity Inc. | 65.19 Million USD | 9359.023% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -190368.823% |
| Celcuity Inc. | 6.78 Million USD | 89079.863% |
| Virax Biolabs Group Limited | -3.36 Million USD | -179277.636% |
| Cibus, Inc. | -8.07 Million USD | -74620.933% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -142627.761% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 132177.834% |
| IN8bio, Inc. | -16.38 Million USD | -36729.318% |
| Kodiak Sciences Inc. | -103.87 Million USD | -5710.789% |
| Annexon, Inc. | -193.75 Million USD | -3015.252% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 16766647.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -34393.154% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -171717.734% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 672.523% |
| Eyenovia, Inc. | 1.25 Million USD | 479638.207% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 22534.332% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -186022.633% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -18054.892% |
| Arcellx, Inc. | -296.95 Million USD | -1932.596% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -30844.104% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -10152.156% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -29021.228% |
| Moolec Science SA | 117.61 Thousand USD | 5132018.276% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -15619.047% |
| Geron Corporation | 14.76 Million USD | 40991.247% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -15818.448% |
| Royalty Pharma plc | 5.65 Billion USD | 206.675% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -4168.077% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -86258.432% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -112451.104% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -4189.003% |
| Humacyte, Inc. | -22.48 Million USD | -26743.178% |
| Structure Therapeutics Inc. | -124.33 Million USD | -4754.435% |
| 89bio, Inc. | -289.05 Million USD | -1988.183% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -23812.356% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -338428.155% |
| Genelux Corporation | -6.89 Million USD | -87390.317% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -19333.842% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 7320.131% |
| Notable Labs, Ltd. | -9.77 Million USD | -61642.604% |
| Liquidia Corporation | -80.17 Million USD | -7428.384% |
| Mustang Bio, Inc. | -3.73 Million USD | -161462.018% |
| Immunovant, Inc. | -635.22 Million USD | -850.205% |
| Quantum-Si incorporated | -118.55 Million USD | -4991.186% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -34265.503% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -145590.49% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 75295.677% |
| Acasti Pharma Inc. | -23 Million USD | -26137.587% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -179155.91% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -37045.786% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -4282.138% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -193586.003% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -27049.861% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -32405.558% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -3465.707% |
| PepGen Inc. | -60.67 Million USD | -9848.833% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -26170.704% |
| United Therapeutics Corporation | -507.7 Million USD | -1088.883% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -31458.909% |
| Solid Biosciences Inc. | -47.75 Million USD | -12540.748% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -700054.74% |
| Immuneering Corporation | -54.94 Million USD | -10885.881% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -143494.01% |
| Silo Pharma, Inc. | -3.52 Million USD | -171166.444% |
| Belite Bio, Inc | -87.27 Million USD | -6816.338% |
| XOMA Corporation | -29 Million USD | -20713.645% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -8437.784% |
| Bionomics Limited | 227 Million USD | 2758.896% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -5090.792% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -238192.815% |
| uniQure N.V. | -102.95 Million USD | -5762.942% |
| Cassava Sciences, Inc. | -121.13 Million USD | -4882.794% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -144806.046% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 14839.462% |
| Forte Biosciences, Inc. | -11.96 Million USD | -50363.649% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -194973.266% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 5694399.057% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -186022.633% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 67881.662% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -81291.006% |
| Altimmune, Inc. | -134.48 Million USD | -4388.134% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 3147.463% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -238192.815% |
| Compugen Ltd. | -12.9 Million USD | -46675.86% |
| Peak Bio, Inc. | 10.34 Million USD | 58473.934% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -2132746.996% |
| Benitec Biopharma Inc. | -50.58 Million USD | -11833.014% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -5685.004% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 30825.157% |
| Zura Bio Limited | -99.8 Million USD | -5947.69% |
| PolyPid Ltd. | 6.17 Million USD | 97927.504% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 8243.493% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 30825.157% |
| Instil Bio, Inc. | 75.35 Million USD | 8109.71% |
| argenx SE | -2.02 Billion USD | -197.507% |
| Immunome, Inc. | -97.02 Million USD | -6120.776% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -26732.438% |
| Verona Pharma plc | -220.44 Million USD | -2638.103% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -8313.304% |
| Shattuck Labs, Inc. | -121.42 Million USD | -4870.975% |
| CervoMed Inc. | -7.79 Million USD | -77355.104% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -3153.903% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -137927.83% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -4481.719% |
| Moolec Science SA | 117.61 Thousand USD | 5132018.276% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -263711.961% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 38065.862% |
| AnaptysBio, Inc. | -18.15 Million USD | -33154.129% |
| Design Therapeutics, Inc. | -18.15 Million USD | -33155.961% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -8476.117% |
| NeurAxis, Inc. | 145.7 Thousand USD | 4142829.581% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 53838.933% |
| Lumos Pharma, Inc. | -28.49 Million USD | -21084.0% |
| Achilles Therapeutics plc | -126.92 Million USD | -4655.568% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -8313.304% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -920394.258% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -28955.588% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 414052.763% |
| Nutriband Inc. | -251.65 Thousand USD | -2398385.637% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -45727.629% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -81028.454% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 1874.253% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 25530.617% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -1248.903% |
| Palisade Bio, Inc. | -12.06 Million USD | -49936.948% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -4201.842% |
| Beam Therapeutics Inc. | -262.72 Million USD | -2197.469% |
| Neurogene Inc. | -131.95 Million USD | -4474.254% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 27767.57% |
| AEON Biopharma, Inc. | -4.88 Million USD | -123587.643% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -1500.239% |
| Sesen Bio, Inc. | -112.55 Million USD | -5262.769% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -5944.419% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -256990.68% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -15366.502% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -7147.613% |
| Athira Pharma, Inc. | -88.99 Million USD | -6682.05% |
| Vaccinex, Inc. | -1.28 Million USD | -468530.202% |
| HCW Biologics Inc. | 2.85 Million USD | 211393.02% |
| XOMA Corporation | -29 Million USD | -20713.645% |
| Nektar Therapeutics | 210.24 Million USD | 2970.984% |
| Arvinas, Inc. | -313.8 Million USD | -1823.504% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 372026.44% |
| Merus N.V. | -192.88 Million USD | -3029.32% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 10162.444% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -86898.515% |
| Rezolute, Inc. | -68.16 Million USD | -8754.531% |
| Clene Inc. | 3.34 Million USD | 180817.275% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -45672.025% |
| BeyondSpring Inc. | -13.75 Million USD | -43781.912% |
| Synlogic, Inc. | -6.68 Million USD | -90191.055% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 532371.34% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -71289.202% |
| Peak Bio, Inc. | 10.34 Million USD | 58473.934% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -7223.413% |
| Krystal Biotech, Inc. | -350.23 Million USD | -1623.407% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 4962.805% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -3471.657% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -191084.089% |
| MannKind Corporation | 143.89 Million USD | 4294.579% |
| Ikena Oncology, Inc. | -109.15 Million USD | -5429.661% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -79624.7% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -18135.52% |
| Gossamer Bio, Inc. | 180.35 Million USD | 3446.709% |
| CohBar, Inc. | -5.93 Million USD | -101674.25% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -20190.295% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 132293.539% |
| Legend Biotech Corporation | -949.39 Million USD | -535.767% |
| Mural Oncology plc | -255.84 Million USD | -2259.243% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 18836.48% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -128034.488% |
| Disc Medicine, Inc. | -358.28 Million USD | -1584.699% |
| Champions Oncology, Inc. | 4.81 Million USD | 125535.515% |
| REGENXBIO Inc. | 54.76 Million USD | 11120.956% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -2244526.209% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -3896.687% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -66876.842% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -7381.077% |
| Vaxart, Inc. | -8.24 Million USD | -73143.017% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -11928.619% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -4646.531% |
| Cellectis S.A. | -43.85 Million USD | -13663.441% |
| Longeveron Inc. | -2.9 Million USD | -207463.858% |
| Repare Therapeutics Inc. | -107.85 Million USD | -5496.207% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 723.306% |
| Inozyme Pharma, Inc. | 12 Million USD | 50382.881% |
| Revolution Medicines, Inc. | -608.2 Million USD | -892.423% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -490628.211% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -2176.714% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -3922.041% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -38475.81% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -815569.865% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 36.888% |
| Denali Therapeutics Inc. | -74.86 Million USD | -7962.455% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -50234.452% |
| Veru Inc. | 4.77 Million USD | 126376.07% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -53572.035% |
| Cingulate Inc. | 3.08 Million USD | 195902.066% |
| Passage Bio, Inc. | 4.58 Million USD | 131745.736% |
| Context Therapeutics Inc. | -14.44 Million USD | -41671.829% |
| Exicure, Inc. | 5.84 Million USD | 103296.393% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -2520.046% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -15153.872% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 38567.637% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -10161.568% |
| Nuvalent, Inc. | -335.38 Million USD | -1699.699% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 348125.965% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -8003.914% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -67796.029% |
| OmniAb, Inc. | 9.2 Million USD | 65686.841% |
| Anew Medical, Inc. | 1.43 Million USD | 421468.55% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 36945.607% |
| Lipocine Inc. | -4.75 Million USD | -126850.052% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -5395.827% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 39729.42% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -11814.874% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 24348.582% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -89707.424% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -9069.424% |
| Ocugen, Inc. | -32.52 Million USD | -18460.183% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -6953.412% |
| Q32 Bio Inc. | -37.94 Million USD | -15805.863% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -961039.65% |
| Alumis Inc. Common Stock | -13.52 Million USD | -44514.953% |
| Equillium, Inc. | -22.39 Million USD | -26855.864% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -23507.466% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -18400.015% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -2434588.099% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 4603.034% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 188841.62% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 1837859.902% |
| Dominari Holdings Inc. | 195 Thousand USD | 3095462.564% |
| Edesa Biotech, Inc. | -5.26 Million USD | -114501.484% |
| vTv Therapeutics Inc. | -8.91 Million USD | -67590.445% |
| Bio-Techne Corporation | 267.74 Million USD | 2354.351% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -37138.306% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -5011.146% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -71730.977% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -47611.303% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -2362.46% |
| Nkarta, Inc. | 57.29 Million USD | 10634.14% |
| BioCardia, Inc. | 212 Thousand USD | 2847249.528% |
| Iterum Therapeutics plc | 13.43 Million USD | 45017.078% |